Bought a few MKTY. Looks undervalued around $1. Company earned .03-.04/share the past 2 quarters. Solid balance sheet with .36/share in cash. Couple of easy comps coming up...hoping to see profits vs. prior year losses. MKTY numbers could be volatile, but the backlog looks encouraging. Backlog jumped to $846K last quarter. That's up from $349K at the start of the year, and up sequentially from $575K.